We are D-Galactose CAS:59-23-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | White to off-white crystalline powder | Conform |
| Assay | ≥99.0% | 99.49% |
| Residue on ignition | ≤0.1% | 0.062% |
| Chloride(Cl) | ≤0.005% | Conform |
| Specific rotation | +78~+81.5 | +80.012 |
| Loss on drying | ≤1.0% | 0.16% |
| Colonies number (CFU/g) | ≤1000 | ND |
| Conclusion | Conforms to Factory Standard | |
Related News: An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug.2,2-Dimethyl-1-oxaspiro[2.2]pentan China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.carbonyldi-iodobis[o-phenylenebis(dimethylarsine)]osmium The company’s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients.5-Fluoro-2-methylindole CAS:399-72-4 The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.
| Product Name | |
|---|---|
| bismuth oxychloride Cas:7787-59-9 | View Details |
| Rubidium Bromide Cas:7789-39-1 | View Details |
| 1,8-DIIODOOCTANE | View Details |